ProCore Ltd Information

Procore is a biotechnology company singly focused on developing solutions that improve the quality of lives of patients suffering from joint and bone diseases. The company’s flagship RegenoGel family is based on proprietary HAProLink technology, a platform technology that links hyaluronic acid to a protein of choice to create a microenvironment for the body to heal itself via natural, gentle cartilage and bone regeneration. RegenoGel products are approved by Israel’s Ministry of Health and have been commercially available since 2016. RegenoGel and the company’s platform technologies are based on the seminal work in biomimetic innovation of Prof. Avner Yayon’s, Procore’s founder.

Website	https://regenogel.co.il/
Revenue	$5.8 million
Employees	5 (4 on RocketReach)
Address	7 Golda Meir St, Ness Ziona, Central District, IL
Phone	+972 8-930-3000
Technologies	JavaScript , HTML , PHP +11 more (view full list)
Industry	Biotechnology Research, Manufacturing General, Manufacturing
Keywords	Biotechnology, Regenerative Medicine, Joint Health, Bone Health, Orthopedic Solutions, Tissue Repair, Cartilage Regeneration, Drug Delivery, Biomaterials, Hyaluronic Acid, Pain Management, Medical Technology, Pharmaceutical Research, Therapeutic Solutions, Osteoarthritis Treatment, Rheumatoid Arthritis Treatment, Clinical Trials, Research And Development, Patient Care, Healthcare Innovation
Competitors	Johnson & Johnson, Medtronic, 3M, Smith+Nephew, B. Braun Group, Coloplast, 墨尼克医疗用品（上海）有限公司, Acelity, KCI USA, Convatec Infusion Care +31 more (view full list)
SIC	SIC Code 28 Companies, SIC Code 80 Companies, SIC Code 283 Companies
NAICS	NAICS Code 32 Companies, NAICS Code 325 Companies, NAICS Code 3254 Companies